Japan health ministry panel approves Novavax’s COVID-19 vaccine

A Japanese Health Ministry committee has approved Novavax Inc’s COVID-19 vaccine, according to Kyodo news agency, Report informs referring to Reuters.

The decision of the experts means that the Novavax vaccine will soon be approved at the level of the Japanese Ministry of Health.

Japan currently uses vaccines from the American companies Pfizer and Moderna, as well as the British-Swedish company AstraZeneca.